Alvarez Cordero R
Rev Gastroenterol Mex. 1979 Jul-Sep;44(3):135-46.
In order to evaluate the efficacy of Caerulein in the postoperative stage of abdominal surgery, 25 patients received 0.3 mcg/kg intravenously every 4 hours. Bowel Movements, passage of gases, first evacuation and general improvement were compared to 25 patients in similar conditions who didn't receive the drug. The study group showed an earlier appearance of intestinal motility as compared to the control group. This contributed in a relevant matter to an earlier discharge from the hospital. The differences with the control group were statistically significative. The benefits of the drug in the management of the postoperative stage of abdominal surgery are discussed.
为了评估蛙皮素在腹部手术后阶段的疗效，25例患者每4小时静脉注射0.3微克/千克。将其排便、排气、首次排便及总体恢复情况与25例未接受该药物治疗的类似病情患者进行比较。研究组与对照组相比，肠道蠕动出现得更早。这在很大程度上有助于患者更早出院。与对照组的差异具有统计学意义。文中讨论了该药物在腹部手术后阶段管理中的益处。
